top of page
Photography by:
Damianos Photography

Intellia

Location

130 Brookline St

Cambridge, MA

By the numbers

Science & Technology

1 Floor

10,000 SF

Completed Spring 2014

Collaborators
  • MIT Investment Management Company - Owner/ Landlord 

  • The Richmond Group - Construction Manager 

  • AHA Engineers - MEP Consultant 

  • VIVO - Building Code  

Featured In

Intellia is at the forefront of the promising CRISPR/ Cas9 technology which can modify, insert or delete DNA sequences of cells. With great potential to cure human genetic disease, the company was founded by Atlas Ventures and Caribou Biosciences.


As part of the building renovations at 130 Brookline, MITIMCo commissioned our firm to design a speculative lab suite which was selected by Intellia for their new facilities. The light filled open space with glass enclosed offices and meeting rooms offered direct visuals to the science spaces with full height glazed partitions. Analytica and tissue culture rooms were modified to meet the new tenant requirements. Bright orange accent walls and dynamic flooring patterns provide visual interest.

Intellia

10,000 SF

1 Floor

Collaborators

130 Brookline St

Cambridge, MA

Completed Spring 2014

  • MIT Investment Management Company - Owner/ Landlord 

  • The Richmond Group - Construction Manager 

  • AHA Engineers - MEP Consultant 

  • VIVO - Building Code  

Intellia is at the forefront of the promising CRISPR/ Cas9 technology which can modify, insert or delete DNA sequences of cells. With great potential to cure human genetic disease, the company was founded by Atlas Ventures and Caribou Biosciences.

As part of the building renovations at 130 Brookline, MITIMCo commissioned our firm to design a speculative lab suite which was selected by Intellia for their new facilities. The light filled open space with glass enclosed offices and meeting rooms offered direct visuals to the science spaces with full height glazed partitions. Analytica and tissue culture rooms were modified to meet the new tenant requirements. Bright orange accent walls and dynamic flooring patterns provide visual interest.

  • Intellia is at the forefront of the promising CRISPR/ Cas9 technology which can modify, insert or delete DNA sequences of cells. With great potential to cure human genetic disease, the company was founded by Atlas Ventures and Caribou Biosciences.


    As part of the building renovations at 130 Brookline, MITIMCo commissioned our firm to design a speculative lab suite which was selected by Intellia for their new facilities. The light filled open space with glass enclosed offices and meeting rooms offered direct visuals to the science spaces with full height glazed partitions. Analytica and tissue culture rooms were modified to meet the new tenant requirements. Bright orange accent walls and dynamic flooring patterns provide visual interest.

bottom of page